share_log

腾盛博药-B(02137)授出合共575.25万份购股权及82.15万份受限制股份单位

Tengsheng Pharmaceutical-B (02137) granted a total of 5.752,500 share options and 821,500 restricted share units

Zhitong Finance ·  Mar 28 13:18

Tengsheng Pharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company purchased shares in accordance with 2023...

According to Zhitong Finance App, Tengsheng BioPharmaceutical-B (02137) issued an announcement. On March 28, 2024, the company granted a total of 5.752,500 share purchase rights to 55 share purchase rights under the terms of the 2023 share purchase plan, and granted a total of 821,500 restricted share units to 18 restricted share unit grantees in accordance with the terms of the 2023 share award plan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment